2-chloro-9-cyclohexyl-7,7-difluoro-5-methyl-6,8-dihydropyrimido[4,5-b][1,4]diazepine
C14H19ClF2N4 — CID 87561091
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-chloro-9-cyclohexyl-7,7-difluoro-5-methyl-6,8-dihydropyrimido[4,5-b][1,4]diazepine
2-chloro-9-cyclohexyl-7,7-difluoro-5-methyl-6,8-dihydropyrimido[4,5-b][1,4]diazepine (PubChem CID 87561091) has the molecular formula C14H19ClF2N4 and a molecular weight of 316.78 g/mol. Its IUPAC name is 2-chloro-9-cyclohexyl-7,7-difluoro-5-methyl-6,8-dihydropyrimido[4,5-b][1,4]diazepine.
Molecular Properties
| Compound Name | 2-chloro-9-cyclohexyl-7,7-difluoro-5-methyl-6,8-dihydropyrimido[4,5-b][1,4]diazepine |
|---|---|
| PubChem CID | 87561091 |
| Molecular Formula | C14H19ClF2N4 |
| Molecular Weight | 316.78 g/mol |
| Exact Mass | 316.13 |
| IUPAC Name | 2-chloro-9-cyclohexyl-7,7-difluoro-5-methyl-6,8-dihydropyrimido[4,5-b][1,4]diazepine |
| SMILES | CN1CC(F)(F)CN(C2CCCCC2)c2nc(Cl)ncc21 |
| InChI | InChI=1S/C14H19ClF2N4/c1-20-8-14(16,17)9-21(10-5-3-2-4-6-10)12-11(20)7-18-13(15)19-12/h7,10H,2-6,8-9H2,1H3 |
| InChIKey | YILYRYHNAMYRSW-UHFFFAOYSA-N |
| XLogP | 3.35 |
| TPSA | 32.26 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 316.78 |
| LogP ≤ 5 | 3.35 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 87561091 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.